Compliance with ethical standards. Conflict of interest: Dr. Patel has received consulting fees from FVC Health, Arrivo Bio, Alosa Health, Guidepoint, and Mirador Therapeutics, and grant support from Amgen, unrelated to the current work. She also serves on the Independent Data Monitoring Committee for AstraZeneca/Everest Clinical Research. Dr. Sparks has received research support from Boehringer Ingelheim, Bristol Myers Squibb, Johnson & Johnson, and Sonoma Biotherapeutics unrelated to this work. He has performed consultancy for AbbVie, Amgen, Anaptys, Boehringer Ingelheim, Bristol Myers Squibb, Fresenius Kabi, Gilead, GSK, Inova Diagnostics, Invivyd, Johnson & Johnson, Merck, MustangBio, Novartis, Optum, Pfizer, ReCor, Sana, Sobi, and UCB unrelated to this work. The funders had no role in the decision to publish or preparation of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. All other authors have no conflicts of interest to report.
PubMed
